Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual H1/PAF antagonists disclosed by British Biotech

April 10, 1997

Quinolone PDE IV/TNF inhibitors from Chiroscience

April 9, 1997

RPR's Tilade approved for pediatric use

April 8, 1997

Clinical comparison of cromolyn and furosemide in asthmatics

April 8, 1997

PDE IV and/or TNF production inhibitors from Pfizer

April 7, 1997

Leukotriene antagonists claimed by Menarini

April 7, 1997

Dual NK1/NK2 receptor antagonists from Rhone-Poulenc Rorer

April 7, 1997

Inhibitors of IgE antibody production characterized by Teijin

April 3, 1997

Fexofenadine introduced in the U.K.

April 1, 1997

Sumitomo Metal characterizes new antiallergic/antiinflammatory agent

April 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...